The most common early side effects nausea, appetite suppression, fatigue, and gastrointestinal discomfort peak within the first day or two after injection and taper across the week
Gujral N, Freeman HJ, Thomson AB (2012) Celiac disease: prevalence, diagnosis, pathogenesis and treatment
The trials included in the meta-analysis are the EXSCEL study (exenatide), LEADER study (liraglutide), SUSTAIN 6 study (semaglutide) and HARMONY outcomes study (albiglutide), ELIXA study (lixisenatide) and REWIND study (dulaglutide)
Benefits include: Better value than purchasing individual vials separately Fewer repeat orders throughout the year Ideal for regular MT2 users Popular for restocking existing supplies Suitable for customers creating additional nasal spray bottles Allows users to mix one vial at a time as needed For those planning long-term use, the 50mg package often represents the ideal balance between convenience and value
but keeping it off